Filing Details

Accession Number:
0001104659-20-079248
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-30 21:01:10
Reporting Period:
2020-06-29
Accepted Time:
2020-06-30 21:01:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1621227 Adaptimmune Therapeutics Plc ADAP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1577539 Gavin Wood C/O Adaptimmune Therapeutics Plc,
60 Jubilee Avenue, Milton Park
Abingdon X0 OX14 4RX
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share Acquisiton 2020-06-29 33,000 $1.62 33,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The ordinary shares whose purchase is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by Gavin Wood. Each ADS represents six ordinary shares of Adaptimmune Therapeutics plc.
  2. The 33,000 ordinary shares reported in Column 4 are represented by 5,500 ADSs.
  3. The price reported in Column 4 of $1.62 per ordinary share is derived from the purchase price paid on June 29, 2020 of $9.7497 per ADS divided by six.